J&J wins approval for expanded use of HIV drug
New Brunswick-based Johnson & Johnson won US approval to expand use of the HIV drug Prezista to newly diagnosed patients.
CNN debates a new pill for preventing the spread of HIV, which may soon be approved by the FDA.